Scivanta Medical Corp. | Income Statement
Fiscal year is November-October. All values USD Thousands.
2011
2012
2013
2014
2015
Sales/Revenue
132.00
-
-
-
-
SG&A Expense
769.70
267.60
325.80
426.20
236.30
EBIT
637.70
267.60
325.80
426.20
236.30
Unusual Expense
-
8.30
68.10
80.70
-
Non Operating Income/Expense
48.40
-
-
-
-
Interest Expense
24.20
27.20
32.70
78.90
70.90
Pretax Income
613.50
303.10
290.50
424.40
307.20
Consolidated Net Income
613.50
303.10
290.50
424.40
307.20
Net Income
613.50
303.10
290.50
424.40
307.20
Net Income After Extraordinaries
613.50
303.10
290.50
424.40
307.20
Net Income Available to Common
613.50
303.10
290.50
424.40
307.20
EPS (Basic)
0.20
0.10
0.06
0.07
0.05
Basic Shares Outstanding
3,019.60
3,101.70
4,730.10
6,148.10
6,359.10
EPS (Diluted)
0.20
0.10
0.06
0.07
0.05
Diluted Shares Outstanding
3,019.60
3,101.70
4,730.10
6,148.10
6,359.10
EBITDA
637.70
267.60
325.80
426.20
236.30
About Scivanta Medical
View Profile
